ABEV Stock Analysis: Ambev | NYSE
Beverages - Brewers | NYSE, USA | Market Cap: 43.176m USD | 12M Return: 35.5% | US02319V1035 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 76.3M
EPS Trend: -71.4%
Qual. Beats: 0
Rev. Trend: 75.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ambev S.A. is one of the largest beverage producers in Latin America, operating through subsidiaries in Brazil, Central America and the Caribbean, Latin America South, and Canada. The company produces, distributes, and sells beer, draft beer, soft drinks, malt, food, and other beverages. Its portfolio spans beer, ready-to-drink cocktails, spritzers, soft drinks, water, teas, and isotonic drinks marketed under well-known regional brands including Brahma, Skol, Antarctica, Quilmes, and Guaraná Antarctica, among others. Ambev sells through a broad network of distributors, supermarkets, and retailers.
The company was founded in 1853 and is headquartered in São Paulo, Brazil. It trades on the NYSE as an ADR under the ticker ABEV and operates as a subsidiary of Interbrew International B.V., linking it to the global AB InBev group, the worlds largest brewer by volume. As a large-cap Consumer Staples company in the Brewers sub-industry, Ambev benefits from stable, recurring demand for its products, though the business is sensitive to commodity input costs such as aluminum, grain, and sugar.
- Brazil beer pricing rebounds as volumes stabilize
- Aluminum and barley cost inflation squeezes gross margins
- Heineken Brasil Kirin deal intensifies core market competition
| Net Income: 16.2b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 2.15 > 1.0 |
| NWC/Revenue: 0.97% < 20% (prev 4.27%; Δ -3.31% < -1%) |
| CFO/TA 0.20 > 3% & CFO 28.0b > Net Income 16.2b |
| Net Debt (-12.7b) to EBITDA (29.7b): -0.43 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.6b) vs 12m ago -0.99% < -2% |
| Gross Margin: 51.90% > 18% (prev 51.50%; Δ 0.41% > 0.5%) |
| Asset Turnover: 62.97% > 50% (prev 64.52%; Δ -1.55% > 0%) |
| Interest Coverage Ratio: 8.50 > 6 (EBIT TTM 23.1b / Interest Expense TTM 2.72b) |
| A: 0.01 (Total Current Assets 40.5b - Total Current Liabilities 39.6b) / Total Assets 138b |
| B: 0.05 (Retained Earnings 7.52b / Total Assets 138b) |
| C: 0.17 (EBIT TTM 23.1b / Avg Total Assets 140b) |
| D: 1.79 (Book Value of Equity 88.3b / Total Liabilities 49.3b) |
| Altman-Z'' = 3.21 = A |
| DSRI: 0.97 (Receivables 8.25b/8.82b, Revenue 88.3b/91.7b) |
| GMI: 0.99 (GM 51.50% / 51.90%) |
| AQI: 1.00 (AQ_t 0.52 / AQ_t-1 0.52) |
| SGI: 0.96 (Revenue 88.3b / 91.7b) |
| TATA: -0.09 (NI 16.2b - CFO 28.0b) / TA 138b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of August 17, 2026, the stock is trading at USD 2.80 with a total of 37,047,782 shares traded. Over the past week, the price has changed by -6.67%, over one month by -8.20%, over three months by -10.57% and over the past year by +35.46%.
Current recommended Stop Loss: 2.70 (which is 3.6% or 1.4 ATR below the current price).
Ambev has received a consensus analysts rating of 3.42. Therefore, it is recommended to hold ABEV.
- StrongBuy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 3.3 | 19.3% |
Market Cap BRL = 226b (43.2b USD * 5.2231 USD.BRL)
P/E Trailing = 14.0
P/E Forward = 13.5318
P/S = 0.4891
P/B = 2.5415
P/EG = 1.9567
Revenue TTM = 88.3b BRL
EBIT TTM = 23.1b BRL
EBITDA TTM = 29.7b BRL
Long Term Debt = 1.88b BRL (from longTermDebt, last quarter)
Short Term Debt = 1.07b BRL (from shortTermDebt, last quarter)
Debt = 5.68b BRL (from shortLongTermDebtTotal, last quarter) + Leases 2.73b
Net Debt = -12.7b BRL (calculated: Debt 5.68b - CCE 18.3b)
Enterprise Value = 213b BRL (226b + Debt 5.68b - CCE 18.3b)
Interest Coverage Ratio = 8.50 (Ebit TTM 23.1b / Interest Expense TTM 2.72b)
EV/FCF = 8.86x (Enterprise Value 213b / FCF TTM 24.0b)
FCF Yield = 11.29% (FCF TTM 24.0b / Enterprise Value 213b)
FCF Margin = 27.22% (FCF TTM 24.0b / Revenue TTM 88.3b)
Net Margin = 18.41% (Net Income TTM 16.2b / Revenue TTM 88.3b)
Gross Margin = 51.90% ((Revenue TTM 88.3b - Cost of Revenue TTM 42.5b) / Revenue TTM)
Gross Margin QoQ = 51.86% (prev 51.56%)
Tobins Q-Ratio = 1.54 (Enterprise Value 213b / Total Assets 138b)
Interest Expense / Debt = 47.95% (Interest Expense 2.72b / Debt 5.68b)
Taxrate = 17.94% (3.66b / 20.4b)
NOPAT = 19.0b (EBIT 23.1b * (1 - 17.94%))
Current Ratio = 1.02 (Total Current Assets 40.5b / Total Current Liabilities 39.6b)
Debt / Equity = 0.06 (Debt 5.68b / totalStockholderEquity, last quarter 88.3b)
Debt / EBITDA = -0.43 (Net Debt -12.7b / EBITDA 29.7b)
Debt / FCF = -0.53 (Net Debt -12.7b / FCF TTM 24.0b)
Total Stockholder Equity = 89.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.59% (Net Income 16.2b / Total Assets 138b)
RoE = 18.13% (Net Income TTM 16.2b / Total Stockholder Equity 89.6b)
RoCE = 25.30% (EBIT 23.1b / Capital Employed (Equity 89.6b + L.T.Debt 1.88b))
RoIC = 19.93% (NOPAT 19.0b / Invested Capital 95.2b)
WACC = 7.85% (E(226b)/V(231b) * Re(7.06%) + D(5.68b)/V(231b) * Rd(47.95%) * (1-Tc(0.18)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.95 | Cagr: -0.74%
[DCF] Terminal Value 76.77% ; FCFF base≈23.1b ; Y1≈25.3b ; Y5≈31.8b
[DCF] Fair Price = 32.36 (EV 486b - Net Debt -12.7b = Equity 499b / Shares 15.4b; r=8.35% [WACC [floored]]; 5y FCF grow 10.93% → 2.50% )
EPS Correlation: -71.38 | EPS CAGR: -5.34% | SUE: 0.0 | # QB: 0
Revenue Correlation: 75.12 | Revenue CAGR: 4.74% | SUE: -0.08 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.04 | Chg30d=-10.04% | Revisions=-25% | Analysts=3
EPS current Year (2026-12-31): EPS=0.20 | Chg30d=+2.55% | Revisions=+38% | GrowthEPS=+12.3% | GrowthRev=+2.9%
EPS next Year (2027-12-31): EPS=0.22 | Chg30d=-0.23% | Revisions=-12% | GrowthEPS=+7.0% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: +7% (up=6, down=5)